Health

ADVANZ PHARMA makes key changes to senior leadership to further accelerate next phase of growth

Dr. Steffen Wagner appointed as new Chief Executive Officer and Andreas Stickler as new Chief Financial Officer ADVANZ PHARMA Corp. Limited (“ADVANZ PHARMA” or “the Company”), a specialty pharmaceutical company with a strategic focus on complex medicines in Europe, today announced several changes in senior leadership roles as it enters the next phase of its growth […]

thaipr.net

18 พ.ย. 64

FDI World Dental Federation: Prescribing of dental antibiotics up 22% in England during first year of COVID-19

Prescriptions of all other antibiotics fell during the same period After years of consecutive decline, the rate of dental antibiotic prescribing increased by over a fifth in 2020 due to COVID-19 restrictions. Dentistry was the only part of England’s publicly-funded National Health Service to experience an increase. The steepest rise occurred when dental practices were […]

thaipr.net

18 พ.ย. 64

Novavax Confirms European Medicines Agency Review of COVID-19 Vaccine Filing for Conditional Marketing Authorization

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that European Medicines Agency (EMA) has begun its evaluation of an application for conditional marketing authorization (CMA) for Novavax’ COVID-19 vaccine, which will be marketed in the European Union under the brand name Nuvaxovid™. EMA’s statement […]

thaipr.net

18 พ.ย. 64

RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients

– Recruitment completed for Part A of the Phase 2/3 study of once-daily orally-administered RHB-107 (upamostat) for patients with symptomatic COVID-19 who do not require hospital care – Top-line results for Part A of the study, designed to evaluate safety and tolerability of RHB-107 and dose selection, expected in Q1/ 22 – RHB-107 is a novel, investigational antiviral […]

thaipr.net

17 พ.ย. 64

Novavax Announces Submission of Biologics License Application in South Korea for Approval of NVX-CoV2373

SK bioscience submits application for NVX-CoV2373, the first protein-based COVID-19 vaccine candidate for BLA, to South Korea’s MFDS Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and SK bioscience, Co. Limited (SK bioscience), a biotechnology company in South Korea, today announced the submission of a Biologics […]

thaipr.net

16 พ.ย. 64
1 … 93 94 95 96 97 … 133

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.